Global Aquaculture Vaccines Market By Overview
Aquaculture vaccination is a method of inducing protective immune responses in fish against harmful bacteria by exposing them to non-pathogenic forms or components of microorganisms. One of the most affordable methods of preventing infectious disease in both food-producing and companion animals is immunization.
Aquaculture vaccination demand increase as a result of the increased vulnerability to infectious illnesses brought on by intensive fish farming. Salmon from farms is more likely to be affected by sea lice infestations. The mortality of over 2.5 million fish due to an anemia epidemic in an aquaculture plant and many more example like this may spur the development of the Aquaculture Vaccine Market.
Attributes |
Details |
Aquaculture Vaccine Market Value (2022) |
US$ 381.4Mn |
Aquaculture Vaccine Market Projected Value (2032) |
US$ 946.5Mn |
Aquaculture Vaccine Market CAGR (2022 – 2032) |
9.0% |
Global Aquaculture Vaccines Market By Drivers & Restraints
Increase in Demand for Marine Food
Due to numerous health advantages, including lowering the risk of cardiac disease for the general population and being rich in micronutrients like Omega-3s, marine food has grown rapidly all over the world. Aquaculture Vaccine Market could develop in the future as a result of consumer’s growing desire for safe, unaffected marine food due to greater awareness of the spread of illnesses in aquatic life.
For instance, in September 2021, Paper Published by Stockholm Resilience Center reported that global demand for aquatic foods set to nearly double by 2050, in which the demand for healthy marine food by improvements to aquaculture production, lower prices, and changing cultural preferences, is increasing.
Government Support for Increase in Marine Production
Government support such as training the fisher youths, establishing fish seed centers with quality seeds, providing infrastructure facility such as fish landing centers, cold storage facility near the farming sites & concession in electricity bills in storages also, new fishing techniques such as impounded fishing to increase the production of marine food which leads to the growth of Aquaculture Vaccine Market.
For instance, in July 2022, by KRISHI JAGRAN, Women and people from the scheduled caste category who wish to start a fish farming business are offered a subsidy of 60% under this scheme. All others receive a subsidy of up to 40% subsidy. Fish farmers can apply for a loan of Rs. 1,60,000 under the ‘PM Matsya Sampada Yojana’ without guarantee through Kisan credit card, in addition, this card allows a maximum loan of Rs 3 lakh.
Restrains:
Strong Government Regulation Policies
Stringent regulatory policies hinder the introduction of new technologies and can limit the manufacturing and approval of Aquaculture Vaccine Market.
Global Aquaculture Vaccines Market By Segmentations & Regional Insights
Global Aquaculture Vaccines Market is segmented based on Route of Administration, Species, Type of Vaccine, Application and Region.
Route of Administration Insight
On the basis of Route of Administration, Aquaculture Vaccine Market is segmented into Spray vaccination, Oral vaccines, Injection vaccines, and Immersion vaccines. Injection Vaccine segment is expected to dominate the target market growth as injection are efficient way to produce antibody response, it can be administered intramuscularly.
Species Insights
On the basis of Species, Aquaculture Vaccine Market is segmented into Fixed Mounting, Carps, Salmon, Surgeon, and Trout. Salmon Species are expected to dominate the target market growth as vaccines are crucial for disease prevention and maintaining the health of farmed salmon populations.
Type of Vaccine Insights
On the basis of Type of Vaccines, Aquaculture Vaccine Market is segmented into inactivated vaccines, live vaccines, and Other Type of Vaccines. Inactivated Vaccine are expected to dominate target market growth as inactivated pathogens are more stable than live pathogens. Increased stability facilitates the storage and transport of inactivated vaccines.
Application Insights
On the basis of Application, Aquaculture Vaccine Market is segmented into Viral infection, Bacterial infection, Other Applications. Bacterial Infection is expected to dominate the target market growth. Bacterial infections occur when bacteria enter body once in body they increase in number. This causes an immune reaction in body.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
On the basis of region, the Aquaculture Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Europe market is estimated to witness a significantly high revenue share over the forecast period, owing to factors such as Norway being the largest producer and exporter of Salmon Fish, and increasing consumption of sea food in the region due to presence of various micro and macro nutrients.
Moreover, The EU provides a variety of funding schemes to the aquaculture industry, most notably the NextGenerationEU (NGEU) recovery instrument and the EU Multiannual Financial Framework (MFF), which runs from 2021 to 2027. The ultimate objective is to encourage adoption of the Commission's "Strategic Guidelines for a more sustainable and competitive EU aquaculture for the period 2021-2030."
Report Scope:
Attribute |
Details |
Base year for estimation |
2022 |
Forecast period |
2022 – 2032 |
Market representation |
Revenue in USD Million & CAGR from 2022 to 2032 |
Market Segmentation |
By Route of Administration - Spray vaccination, Oral vaccines, Injection vaccines, and Immersion vaccines By Species - Fixed Mounting, Carps, Salmon, Surgeon, and Trout By Type of Vaccine - Inactivated vaccines, Live vaccines, and Other Type of Vaccines By Application - Viral infection, Bacterial infection, Other Applications |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Aquaculture Vaccine Market report based on Route of Administration, Species, Type of Vaccine, Application and Region:
Aquaculture Vaccines Market, By Route of Administration:
- Spray vaccination
- Oral vaccines
- Injection vaccines
- Immersion vaccine
Aquaculture Vaccines Market, By Species:
- Fixed Mounting
- Carps
- Salmon
- Surgeon
- Trout
Aquaculture Vaccines Market, By Type of Vaccine:
- Inactivated vaccines
- Live vaccines
- Other Type of Vaccines
Aquaculture Vaccines Market, By Application:
- Viral infection,
- Bacterial infection,
- Other Applications
Aquaculture Vaccines Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Aquaculture Vaccines Market By Competitive Landscape & Key Players
The key players operating the Aquaculture Vaccine Market includes, Zoetis Inc., Phibro Animal Health Corporation., Elanco, Merck & Co., Inc., KMNP, INC., CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, HIPRA, Veterquimica S.A., TECNOVAX, Virbac S.A., Pfizer, Inc., MICROSYNBIOTIX LIMITED, ICTYOGROUP and ADM and others.
Global Aquaculture Vaccines Market By Company Profile
- Zoetis Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Phibro Animal Health Corporation.
- Elanco, Merck & Co.
- Inc., KMNP, INC.
- CAVAC
- Kyoto Biken Laboratories, Inc.
- Nisseiken Co., Ltd.
- Vaxxinova International BV
- HIPRA, Veterquimica S.A.
- TECNOVAX, Virbac S.A.
- Pfizer, Inc.
- MICROSYNBIOTIX LIMITED
- ICTYOGROUP
- ADM
“*” marked represents similar segmentation in other categories in the respective section
Recent Development:
- In February 2023, a novel vaccination that could shield farmed Atlantic salmon from the lethal infectious hematopoietic necrosis virus (IHNV) was unveiled by University of Maine researchers. An immunological response in the fish is triggered by the vaccine using a viral protein.
- In November 2022, “Indian Immunologicals Ltd (IIL)”, a company based in Hyderabad, announced a partnership with the Central Institute of Fisheries Education (CIFE) to create the nation's first fish vaccine for commercial use. To protect freshwater fish from common bacterial illnesses, a vaccine will be created.
- In November 2021"Bath Vaccinator," an automated device used for aquaculture immunization, has been introduced by “FFF (Fish Farm Feeder)”. The automated equipment can greatly simplify the vaccination process depending on the route of delivery (immersion type).
FAQs
The Aquaculture Vaccine Market is segmented into on Route of Administration, Species, Type of Vaccine, Application and Region.
Aquaculture Vaccine Market is driven by factors like increasing infection in aquatic life due to intensive farming, government funding and increase in demand for sea food.
By region, the Aquaculture Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Europe market is estimated to witness a significantly high revenue share over the forecast period.
The key players operating the Aquaculture Vaccine Market include, Zoetis Inc., Phibro Animal Health Corporation., Elanco, Merck & Co., Inc., KMNP, INC., CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, HIPRA, Veterquimica S.A., TECNOVAX, Virbac S.A., Pfizer, Inc., MICROSYNBIOTIX LIMITED, ICTYOGROUP and ADM and others.
Aquaculture Vaccine Market accounted for US$ 381.4 Million in 2022 and is estimated to be US$ 946.5 Million by 2032 and is anticipated to register a CAGR of 9.0%.